跳至主要内容
临床试验/NCT00429897
NCT00429897Unknown不适用

Double Blind Crossover Comparison od Diuretics in Young Patients With Low Renin Hypertension

University of Cambridge2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2006年8月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
30
试验地点
2
主要终点
Difference in systolic blood pressure for subjects' best drug and second best drug.

研究概览

简要总结

The principle objective of the study is to determine whether low-renin (i.e. salt sensitive) hypertension at a young age is caused by the kidneys hanging onto too much salt as a result of an over active salt pump in the kidney.

The kidneys have four different salt pumps, and each is blocked by a different type of diuretic (salt losing tablet)If one out of the four is overactive, we would expect patients to respond much better to one diuretic than to the alternatives - rather than responding equally well to all available types of diuretic.

详细描述

Studies suggest that patients with low renin hypertension respond better to diuretics than other hypertensive drug groups. The aim of the study is to rotate patients through the four main diuretic groups and see if it is possible to identify the most effective diuretic for this group, as measured by a >=10mgHg decrease in Systolic blood pressure in one specific group a compared to the others.

As most caucasians with Low renin hypertension are older (>55), presentation with this type of hypertension at a younger age suggests the presence of substantial genetic variation in order to cause the atypical presentation. It is hoped that by identifying the best diuretic for these patients we will also be able to identify:

  1. Whether the young low-renin hypertensives can be sub-classified according to their most effective diuretic;
  2. Whether this sub-classification helps us to identify the genes and mutations responsible, since these are to expected to be in the so-called sodium channels (i.e. salt pumps)which the kidneys use to prevent salt being excreted in the urine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-45
  • male or female
  • Hypertensive - 3 clinic SBP >=140mmHg; or 3 clinic DBP >=90mmHg; or ABPM or home BP >=130(SBP) or 85(DBP)
  • 24hr Na+<160mmol/l
  • EITHER {Plasma renin<=10mU/L (measured untreated, or whilst receiving only CCB+/-diuretic} + {Plasma renin <=40mU/L (measured on an ACEi or ARB, which approximately double s the plasma renin)} OR Plasma renin <5mU/L (measured untreated, or receiving any antihypertensive drug other than a beta-blocker

排除标准

  • Documented history of gout
  • Abnormal renal function (both elevated serum creatinine and reduced creatinine clearance
  • SBP > 170mmHg or Diastolic >110mmHg despite treatment with permitted background treatment

结局指标

主要结局

Difference in systolic blood pressure for subjects' best drug and second best drug.

Difference in plasma renin for subjects' best drug and second best drug.

次要结局

  • Predictions of best drug

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验